EVOFEM BIOSCIENCES, INC.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| Operating Expenses | ||||||
| Research & Development | $43.4M | $23.5M | $6.6M | $34.4M | $5.2M | $11.4M |
| SG&A Expense | $34.2M | $12.1M | $5.5M | $7.6M | $4.4M | $3.0M |
| Operating Income | $-77.6M | $-35.7M | $-12.0M | $-42.0M | $-9.6M | $-14.4M |
| Operating Margin | — | — | — | — | — | — |
| Interest Expense | — | — | $1.0M | $1.1M | $374.9K | $56.8K |
| Pretax Income | $-125.7M | $-105.3M | — | — | — | — |
| Income Tax Expense | $2.0K | $3.0K | $0 | $0 | $0 | — |
| Net Income | $-125.7M | $-105.3M | $-13.0M | $-43.2M | $-10.8M | $-15.0M |
| Net Margin | — | — | — | — | — | — |
| EPS (Basic) | $0.00 | $-0.01 | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS (Diluted) | $0.00 | $-0.01 | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares Outstanding (Basic) | 246.26B | 19.82B | 21.94B | 130.90B | 130.15B | — |
| Shares Outstanding (Diluted) | 246.26B | 19.82B | 21.94B | 130.90B | 130.15B | — |
| Dividends Per Share | — | — | — | — | — | — |